Ocera Therapeutics, Inc. (OCRX) - NASDAQ
Company Description
Ocera Therapeutics, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of OCR-002 ornithine phenylacetate. The OCR-002 is an ammonia scavenger which is used to treat hyperammonemia and associated hepatic encephalopathy in patients with liver... More
Sector: Healthcare
Industry: Biotechnology
Country: United States